Jeil Pharma Holdings Inc (KRX: 002620)

Jeil Pharma Holdings Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 14, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	126,493	180,683	236,407	245,618	325,444	260,969
Market Cap Growth	-21.32%	-23.57%	-3.75%	-24.53%	24.71%	-34.11%
Enterprise Value	337,178	429,021	424,544	404,795	543,483	410,501
Last Close Price	8240.00	11770.00	15334.24	15871.34	20946.42	16739.45
PE Ratio	-	-	-	-	28.13	-
PS Ratio	0.16	0.22	0.30	0.32	0.43	0.36
PB Ratio	0.38	0.45	0.56	0.49	0.65	0.54
P/TBV Ratio	0.55	0.67	0.91	0.96	1.39	1.19
P/OCF Ratio	-	-	-	18.33	-	10.35
EV/Sales Ratio	0.43	0.53	0.54	0.53	0.71	0.56
EV/EBITDA Ratio	117.61	12.82	126.46	48721.60	17.73	24.84
EV/EBIT Ratio	-	20.51	-	-	24.70	44.96
EV/FCF Ratio	-56.46	-	-	-	-	-
Debt / Equity Ratio	0.35	0.53	0.39	0.23	0.30	0.25
Debt / EBITDA Ratio	52.71	6.40	48.44	13850.20	4.89	7.42
Asset Turnover	0.88	0.92	0.90	0.86	0.88	0.83
Inventory Turnover	4.34	4.94	5.38	4.88	5.17	5.65
Quick Ratio	0.66	0.61	0.65	0.71	0.63	0.67
Current Ratio	1.03	0.93	0.98	1.12	1.02	1.00
Return on Equity (ROE)	-13.51%	-3.22%	-18.07%	-2.58%	3.05%	-17.83%
Return on Assets (ROA)	-0.73%	1.50%	-0.54%	-0.63%	1.59%	0.65%
Return on Capital (ROIC)	-1.09%	2.18%	-0.79%	-0.89%	2.19%	0.87%
Earnings Yield	-31.26%	-8.99%	-31.54%	-1.42%	3.51%	-34.68%
FCF Yield	-4.72%	-5.89%	-13.84%	-4.19%	-10.29%	-4.78%
Dividend Yield	0.61%	0.42%	0.33%	0.41%	0.33%	0.42%
Payout Ratio	0.00%	-	-	-	13.88%	-
Buyback Yield / Dilution	-	-	-	-	-195.86%
Total Shareholder Return	0.61%	0.42%	0.33%	0.41%	0.33%	-195.44%

Source: S&P Capital IQ. Standard template. Financial Sources.